V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009931 | 190005018 | 1.76 | 70 | Curative (C) | 2020-06-23 | 2020-07-05 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 100621537 |
| 190009932 | 190005019 | 1.6 | 82.2 | Palliative (P) | null | 2019-08-29 | DOXORUBICIN | null | null | DOXORUBICIN | 101741327 |
| 190009940 | 190005020 | 1.71 | 49.1 | Curative (C) | 2016-09-28 | 2016-11-24 | DOXORUBICIN | 01 | N | DOXORUBICIN | 101142333 |
| 190009944 | 190005021 | 0 | 42.8 | Palliative (P) | 2016-05-25 | 2016-09-23 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101284814 |
| 190009950 | 190005022 | 1.74 | 63.3 | Curative (C) | 2019-09-25 | 2019-10-10 | EW EuroEwing 2012 Arm A VIDE | 02 | N | OST MIFAMURTIDE | 100607227 |
| 190009952 | 190005023 | 1.58 | 59 | Curative (C) | 2016-10-06 | 2016-10-06 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 100639670 |
| 190009958 | 190005024 | 1.81 | 67.7 | Curative (C) | 2017-02-25 | 2017-03-19 | EW EuroEwing 2012 Arm A VIDE | 02 | N | EURO-EWING | 100130592 |
| 190009967 | 190005025 | 1.71 | 57 | Neo-adjuvant (N) | 2018-05-12 | 2018-06-01 | EW EuroEwing 2012 Arm B IE | N | N | EW EUROEWING 2012 ARM B IE | 101253879 |
| 190009977 | 190005026 | 1.71 | 67.9 | Palliative (P) | null | 2019-11-16 | PAM x 2 post-surgery (cycles 3&4) | N | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101725784 |
| 190009978 | 190005027 | 1.85 | 89.7 | null | 2021-10-11 | 2021-10-11 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100339864 |
| 190009987 | 190005028 | null | 82.7 | Curative (C) | null | 2016-06-07 | Trial Unspecified | N | null | TRIAL UNSPECIFIED | 100962902 |
| 190009989 | 190005029 | 1.68 | 153.2 | Palliative (P) | 2022-05-01 | 2022-05-06 | VIP | N | N | EW EUROEWING 2012 ARM A VAI | 101009189 |
| 190009996 | 190005030 | 1.73 | 82.7 | null | 2021-03-21 | 2021-04-09 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101230444 |
| 190009998 | 190005031 | null | 52.5 | null | null | 2017-09-19 | OST Euramos 1 Closed Trial - A | 02 | Y | OST A | 100939454 |
| 190009999 | 190005032 | 1.61 | 66.3 | Palliative (P) | 2021-05-01 | 2021-05-10 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | N | ATEZOLIZUMAB | 101464017 |
| 190010002 | 190005033 | 1.66 | 88.1 | Palliative (P) | 2020-01-07 | 2020-01-31 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100064157 |
| 190010003 | 190005034 | 1.62 | 65.05 | Palliative (P) | null | 2017-09-27 | PAM x 2 post-surgery (cycles 3&4) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101650109 |
| 190010004 | 190005035 | null | 32.6 | Curative (C) | 2014-11-21 | 2015-04-17 | Capecitabine + Cisplatin | 01 | N | CAV | 100734524 |
| 190010011 | 190005036 | 1.76 | 44.2 | Neo-adjuvant (N) | 2020-01-16 | 2020-01-16 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | VAI | 100983073 |
| 190010014 | 190005037 | 1.73 | 70.9 | null | null | 2018-06-05 | VIDE | 01 | N | EW EUROEWING 2012 ARM A VAI | 101366220 |
| 190010029 | 190005039 | 1.75 | 57 | Palliative (P) | 2019-10-09 | 2019-10-30 | DOCETAXEL + GEMCITABINE | 02 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100356421 |
| 190010035 | 190005040 | 1.56 | null | 03 | 2018-01-24 | 2018-02-15 | METHOTREXATE | 02 | N | METHOTREXATE | 101667228 |
| 190010044 | 190005041 | 1.6 | 48.4 | null | 2022-02-25 | 2022-02-25 | Capecitabine | 02 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 101484428 |
| 190010045 | 190005042 | 1.73 | 38 | Curative (C) | 2019-12-07 | 2019-12-07 | OST Euramos 1 Closed Trial - M | null | null | OST M | 100182411 |
| 190010047 | 190005043 | 1.65 | 89 | Curative (C) | null | 2018-03-29 | Avelumab | null | null | IMATINIB | 100937280 |
| 190010048 | 190005044 | 0 | 0 | Curative (C) | 2019-09-04 | 2019-09-17 | Cyclophosphamide + Vincristine | Y | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100546573 |
| 190010050 | 190005045 | 1.79 | 102 | Neo-adjuvant (N) | 2021-01-13 | 2021-07-01 | Dox + HD Mtx (post PAM) | 01 | N | OST IE | 100348450 |
| 190010052 | 190005046 | 1.61 | 89.6 | null | 2018-05-21 | 2018-05-21 | Capecitabine + Oxaliplatin 21day | 01 | N | IRINOTECAN + TEMOZOLOMIDE | 101557901 |
| 190010062 | 190005047 | 1.68 | 75.9 | Adjuvant (A) | 2009-01-29 | 2019-05-22 | Cyclophosphamide + Vincristine | 02 | N | CARBOPLATIN + FLUOROURACIL | 100428148 |
| 190010063 | 190005048 | 1.64 | 84.2 | null | 2017-05-10 | 2017-05-28 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | EURO-EWING | 101523165 |
| 190010073 | 190005049 | 1.68 | 97.6 | null | 2020-02-02 | 2020-02-11 | OST Euramos 1 Closed Trial - M | 01 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 100031238 |
| 190010076 | 190005050 | 0 | 56.4 | Palliative (P) | 2018-01-15 | 2018-01-15 | Cisplatin + Radiotherapy | 02 | N | EURAMOS TRIAL | 100360558 |
| 190010079 | 190005051 | 0 | 54.3 | null | null | 2019-01-29 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100830105 |
| 190010083 | 190005052 | 1.78 | 82.7 | Palliative (P) | 2019-07-08 | 2019-07-14 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | 02 | null | OST IE | 101195942 |
| 190010085 | 190005053 | 1.66 | 36.35 | Curative (C) | 2016-01-16 | 2016-09-17 | Etoposide oral | 2 | N | DOXORUBICIN + METHOTREXATE | 100022744 |
| 190010086 | 190005054 | 0 | 41 | Curative (C) | 2017-11-19 | 2017-11-21 | CNS ATRT Carboplatin/Thiotepa + GCSF | 02 | null | EURO-EWING | 100813051 |
| 190010088 | 190005055 | 1.92 | 70.5 | Palliative (P) | null | 2019-05-29 | Docetaxel + Gemcitabine (prior RT) | N | N | DOCETAXEL + GEMCITABINE | 100675486 |
| 190010091 | 190005056 | 1.84 | 81 | Curative (C) | 2019-03-08 | 2019-09-07 | Cisplatin + Radiotherapy | N | N | CISPLATIN + DOXORUBICIN | 101727589 |
| 190010093 | 190005057 | 0 | 36 | Neo-adjuvant (N) | 2018-09-11 | 2018-11-07 | EURAMOS TRIAL | N | N | OST MIFAMURTIDE | 101125124 |
| 190010098 | 190005058 | 1.5 | 89.8 | Palliative (P) | 2019-07-22 | 2019-10-29 | CAPECITABINE + IRINOTECAN | N | N | TRABECTEDIN | 101428675 |
| 190010109 | 190005059 | null | 65 | Neo-adjuvant (N) | 2017-05-14 | 2017-11-18 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100844569 |
| 190010110 | 190005060 | 1.88 | 77 | Neo-adjuvant (N) | null | 2015-09-08 | EW EuroEwing 2012 Arm B VC | null | null | EW EUROEWING 2012 ARM B VC | 100128225 |
| 190010111 | 190005061 | 1.74 | 100 | Curative (C) | 2016-07-09 | 2016-07-25 | Doxorubicin + Olaratumab | 01 | N | CISPLATIN + DOXORUBICIN | 101241255 |
| 190010113 | 190005062 | 0 | 64.9 | Palliative (P) | 2022-02-27 | 2022-03-13 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100094259 |
| 190010114 | 190005063 | 1.58 | 34 | Adjuvant (A) | 2019-08-12 | 2019-12-13 | EW EuroEwing 2012 Arm A VAC | 1 | null | MAP | 101177950 |
| 190010117 | 190005064 | 1.74 | 98.7 | Palliative (P) | 2019-01-12 | 2019-01-28 | null | 02 | null | EURAMOS TRIAL | 100494715 |
| 190010119 | 190005065 | 1.62 | 106.3 | Neo-adjuvant (N) | 2018-01-21 | 2018-01-21 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101557171 |
| 190010122 | 190005066 | null | 69.8 | Adjuvant (A) | 2019-03-01 | 2019-03-22 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 100562215 |
| 190010123 | 190005067 | 1.84 | 53 | Palliative (P) | 2016-10-31 | 2017-03-14 | null | 01 | N | DOXORUBICIN + METHOTREXATE | 100042074 |
| 190010126 | 190005068 | 1.61 | 53.5 | Palliative (P) | 2019-12-01 | 2020-04-27 | PAM x 2 pre-surgery (cycles 1&2) | 01 | N | CISPLATIN | 100810176 |